BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $6,853,000 | -48.5% | 45,333 | -50.4% | 0.00% | -40.0% |
Q2 2022 | $13,312,000 | +35.9% | 91,363 | +10.6% | 0.01% | +66.7% |
Q1 2022 | $9,794,000 | +33.6% | 82,599 | +55.3% | 0.00% | +50.0% |
Q4 2021 | $7,330,000 | -28.9% | 53,186 | -28.3% | 0.00% | -33.3% |
Q3 2021 | $10,303,000 | +538.0% | 74,176 | +346.0% | 0.00% | +200.0% |
Q2 2021 | $1,615,000 | +42.2% | 16,633 | +0.0% | 0.00% | – |
Q1 2021 | $1,136,000 | -50.8% | 16,625 | -38.3% | 0.00% | -100.0% |
Q4 2020 | $2,311,000 | +20.1% | 26,960 | -8.9% | 0.00% | 0.0% |
Q3 2020 | $1,925,000 | – | 29,608 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |